Factors such as growing awareness about various health-related disorders among women, rising incidence of various chronic and lifestyle disorders in women, and high prevalence of infectious diseases such as HIV and hepatitis in women across the globe are driving the growth of the market. Moreover, the increasing adoption of point-of-care diagnostic testing and the increasing number of diagnostic and imaging centers are also expected to play a major role in market growth.
What the Market Looks Like?
The global women’s health diagnostics market is projected to reach USD 36.64 Billion by 2021 from USD 25.03 Billion in 2016, at a CAGR of around 7.9% during the forecast period. In 2015, North America commanded the largest share of the global women health diagnostics market.
This market is mainly driven by the increased adoption of point-of-care & rapid diagnostic tests, growth in the number of private diagnostic centers, high prevalence of infectious diseases in women, rising incidence of chronic & lifestyle-related disorders in women and increasing awareness about fertility testing in women & initiatives taken by government and health organizations.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=128928901
What are Key Trends in the Market?
The growth of the Women’s Health Diagnostics Market is primarily influenced by the following factors:
- High Prevalence of Infectious Diseases in Women
- Rising Incidence of Chronic and Lifestyle-Related Disorders in Women
- Increasing Awareness About Fertility Testing in Women and IniTIAtives Taken By Government and Health Organizations
- Increased Adoption of Point-Of-Care and Rapid Diagnostic Tests
- Growth in the Number of Private Diagnostic and Imaging Centers
- Public-Private Partnerships to Enhance the Infrastructure of Diagnostic Imaging Centers
The global market has been segmented, on the basis of applications, and end users. On the basis of application, the market is segmented into various segments, namely, osteoporosis testing, ovarian cancer testing, cervical cancer testing, breast cancer testing, pregnancy & ovulation testing, prenatal genetic screening & carrier testing, infectious disease testing, sexually transmitted disease testing, and ultrasound.
Read more about Global Breast Cancer Testing Market@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=128928901